跳至主要内容
临床试验/JPRN-UMIN000028525
JPRN-UMIN000028525已完成未知

Effects of functional foods on the blood cholesterol level -A randomized, double-blind, placebo-controlled, parallel-group comparative study- - Effects of functional foods on the blood cholesterol level

HUMA R&D CORP0 个研究点目标入组 75 人开始时间: 2017年8月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Subjects who is taking the following medications within 3 months, or who is scheduled to take medication after informed consent to participate in this examination. Fibrate-based medicine (bezafibrate etc), nicotinic acid, azole antifungal drug (itraconazole etc), macrolide antibiotics(erythromycin etc), coumarin-based anticoagulants(warfarin), antacid(magnesium hydroxide, aluminium hydroxide), lopinavir and ritonavir combination drug,Simeprevir, eltrombopag. 2)Subjects using steroidal and non-steroidal medicines (internal medicine / topical medicine). 3)Subjects who regularly use chemicals (orlistat (Xenical, Arai )etc) affecting fat absorption. 4)Subjects who previous or present serious disease such kidney, liver, circulatory system, benign neoplasm,mental, dementing disorder. 5)Subjects who are alcoholics or previous. 6)Subjects with hypothyroidism, patients with hereditary muscle disease (muscular dystrophy etc) or their family history, or those with a history of drug-induced myopathy. 7)Subjects who are receiving medication in diabetic patients or hypertensive patients. 8)Subjects who have allergy related to the study foods. 9)Subjects who using health foods (supplements, foods for specified health use, displayed functional foods), quasi-drugs, medicines that decrease LDL cholesterol. 10)Subjects who are participating within 3 months or planning to participate in other clinical study. 11)Subjects who are pregnant or breast-feeding. 12)Subjects who are judged as unsuitable for the study by the doctor and the investigator in charge for other reason.

研究者

发起方
HUMA R&D CORP

相似试验